Live Signals
Signals ScoreSignals Score (0–100) blends the three technical signals — MA, RSI and MACD — where BUY = 100, HOLD/NEUTRAL = 50, SELL = 0.
Each signal is weighted by its own historical BUY hit-rate for this ticker (a signal that has been right more often counts for more). Hit-rates from only a handful of past signals are pulled toward equal weight, so a small, noisy sample can't swing the score.
(16.70)
(18.50)
(0.00)
2 of 3 frames agree
Sessions where price opened above the prior high or below the prior low
| Date | Type | Gap % | Prev Close | Open | Filled? |
|---|---|---|---|---|---|
| 2026-11-12 | Gap Down | -2.84% | $172.62 | $167.71 | Open |
| 2026-11-04 | Gap Up | +2.88% | $178.27 | $183.40 | Filled |
| 2026-10-30 | Gap Down | -5.94% | $188.64 | $177.44 | Open |
| 2026-10-29 | Gap Up | +2.02% | $184.69 | $188.42 | Filled |
| 2026-10-27 | Gap Down | -6.57% | $180.17 | $168.34 | Filled |
| 2026-10-08 | Gap Down |
Candlestick patterns identified in recent price action
Doji
2026-11-13
Open and close nearly equal — market indecision. Most significant at swing highs/lows; often precedes a reversal or consolidation.
Support
Resistance
Stockasthics is an educational tool only. Nothing on this page constitutes financial advice. All signals, scores, and data are for informational and learning purposes only.
weekly
Signals from weekly candles smooth out daily noise and reveal the true intermediate trend. More reliable for direction. A BUY on the weekly carries more conviction than a daily BUY alone.
| -1.93% |
| $167.22 |
| $164.00 |
| Open |
| 2026-10-06 | Gap Up | +1.27% | $189.50 | $191.90 | Filled |
| 2026-09-18 | Gap Up | +0.51% | $178.19 | $179.10 | Filled |
RGEN: +62.3% vs SPY: +1.3% → RS: +61.0% Relative Strength = stock return minus index return over the same window. Positive = outperforming the market. Academic research (Jegadeesh & Titman 1993) shows stocks with strong relative momentum tend to keep outperforming for 3–12 months. >+5% → BUY | <-5% → SELL | in between → NEUTRAL
Relative Strength vs SPY
Measures how this stock has performed relative to the S&P 500. Persistent outperformance signals institutional sponsorship and sector leadership. Underperformance warns of rotation out of the stock, even in a rising market.
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Official website ↗5-year in-sample backtest of the combined MA/RSI/MACD signal
| Signal | # Signals | Hit Rate 5d | Hit Rate 10d | Hit Rate 20d | Avg Return 5d | Avg Return 10d | Avg Return 20d |
|---|---|---|---|---|---|---|---|
| BUY | 319 | 50.2% | 46.4% | 41.7% | +0.25% | -0.17% | -1.12% |
| SELL | 537 | 50.3% | 51.4% | 47.9% | +0.32% | +0.83% | +2.16% |
Hit rate = % of BUY signals where price was higher (or SELL signals where it was lower) at the given horizon. Does not account for transaction costs. In-sample only — not a prediction of future performance.
Last 20 trading days
| Date | Close | MA | RSI | MACD | Combined |
|---|---|---|---|---|---|
| 2026-10-19 | $176.43 | HOLD | HOLD | HOLD | BUY |
| 2026-10-20 | $178.88 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-21 | $180.01 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-22 | $178.71 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-23 | $176.93 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-26 | $180.17 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-27 | $175.80 | HOLD | HOLD | HOLD | HOLD |
| 2026-10-28 | $184.69 | HOLD | HOLD | BUY | HOLD |
| 2026-10-29 | $188.64 | HOLD | HOLD | BUY | HOLD |
| 2026-10-30 | $176.94 | HOLD | HOLD | BUY | HOLD |
| 2026-11-02 | $172.95 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-03 | $178.27 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-04 | $178.20 | HOLD | HOLD | HOLD | HOLD |
| 2026-11-05 | $168.48 | HOLD | HOLD | SELL | HOLD |
| 2026-11-06 | $173.49 | HOLD | HOLD | SELL | HOLD |
| 2026-11-09 | $178.94 | HOLD | HOLD | SELL | SELL |
| 2026-11-10 | $173.98 | HOLD | HOLD | SELL | SELL |
| 2026-11-11 | $172.62 | HOLD | HOLD | SELL | SELL |
| 2026-11-12 | $166.52 | HOLD | HOLD | SELL | SELL |
| 2026-11-13 | $167.79 | HOLD | HOLD | SELL | SELL |
| Quarter | EPS Est. | EPS Actual | Surprise | Beat? |
|---|---|---|---|---|
| 2025-12-31 | $0.44 | $0.49 | +10.4% | ✓ |
| 2026-03-31 | $0.39 | $0.48 | +22.9% | ✓ |
| 2026-06-30 | $0.45 | $0.54 | +20.4% | ✓ |
| 2026-09-30 | $0.46 | $0.53 | +14.5% | ✓ |